The Efficacy of Ultrasound-guided Ozone Injection in the Treatment of Patients With Chronic Low Back Pain
1 other identifier
interventional
50
1 country
1
Brief Summary
Low back pain is a common disorder that every individual in the society is likely to meet throughout his/her life. Low back pain lasting longer than 12 weeks is defined as chronic low back pain and causes serious disability in the community. Conservative, pharmacological, interventional and surgical treatment options are available in its treatment. In this study, it was aimed to determine the effects of ultrasound-guided deep paravertebral periforaminal ozone injection treatment on physical examination, functional independence, quality of life and pain scores in patients with chronic low back and leg pain and to compare it with transforaminal epidural steroid injection treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 14, 2022
CompletedFirst Posted
Study publicly available on registry
October 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedOctober 19, 2022
October 1, 2022
1 year
August 14, 2022
October 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
PAİN-Visual Analog Scala (VAS)
Visual Analog Scala (VAS), patients are asked to circle the number between 0 and 10 that fits best to their pain intensity. Severity of pain was assessed VAS using the standard 10 cm (back pain and leg pain) with 0 meant "no pain" at one end, and 10 meant "unbearable pain" at the other end.
2nd week, 4th week, 8th week pain change
Quality of life - Short Form-36 (SF-36)
Satisfaction assessed by the SF-36. Short Form (SF-36) was used to investigate the quality of life of the patients.The reliability and validity of the Turkish version of SF-36 has been demonstrated. SF-36 consists of 36 questions on eight different subscales including physical functioning, role limitations due to physical health problems, bodily pain, general health perceptions, energy and fatigue, vitality, social functioning, role limitations due to emotional problems and general mental health. Each subscale of SF-36 is scored between 0 and 100, and higher scores show better Quality of life.
2nd week, 4th week, 8th week quality of life change
Oswestry Disability Index (ODI)
In the ODI questionnaire, the effect of low back pain on activities of daily living is questioned. In the test, which consists of 10 questions in total, the patient's pain intensity, the effects of pain on personal care, walking, lifting weights, standing, sitting, sleeping, sexual life, social life and traveling are questioned. The patient can get a minimum of 0 and a maximum of 5 points from each question. The maximum score to be taken from the test is 50. The patient's score is found by dividing the total score of the patient by 50, which is the maximum score, and calculating the percentage. (Patient's score ÷ maximum score × 100). Accordingly, it is calculated how much the patient's life activities are affected.
2nd week, 4th week, 8th week pain change
Physical examination-Lumbar joint range of motion examination
Lumbar joint range of motion examination( flexion-extansion-lateral flexion-rotation)
2nd week, 4th week, 8th week examination change
Physical examination-straight leg raise test
straight leg raise test- It is recorded whether there is normal or abnormal
2nd week, 4th week, 8th week examination change
Physical examination-femoral nerve stretch test
femoral nerve stretch test - It is recorded whether there is normal or abnormal
2nd week, 4th week, 8th week examination change
Physical examination-Walleix palpation
Walleix palpation- It is recorded whether there is tenderness in Walleix palpation.
2nd week, 4th week, 8th week examination change
Study Arms (2)
deep paravertebral- periforaminal ozone injection
ACTIVE COMPARATORtransforaminal steroid injeciton
ACTIVE COMPARATORInterventions
Deep paravertebral periforaminal ozone injection was administered to the patients in the ozone injection group 4 times under ultrasound guidance, 10 ug/ml 5ml twice a week in the first week and 15 ug/ml 5ml twice a week in the second week. Patients will be evaluated according to the study criteria at the beginning, at 15 days, 1 month, and 2 months. Physical examination findings were evaluated before starting the treatment and at the 2nd month follow-up.
Transforaminal epidural steroid injection group, steroid (dexamethasone 8mg/2ml 2ml) injection was performed under the guidance of fluoroscopy. Patients will be evaluated according to the study criteria at the beginning, at 15 days, 1 month, and 2 months. Physical examination findings were evaluated before starting the treatment and at the 2nd month follow-up.
Eligibility Criteria
You may qualify if:
- Back and leg pain lasting longer than 3 months
- Diagnosis of lumbar disc herniation with advanced imaging techniques after anamnesis, - physical examination and laboratory examinations
- Continuation of complaints despite conservative treatment before
- Regular participation in the study voluntarily
You may not qualify if:
- Being pregnant and breastfeeding
- History of lomber surgery
- Peripheral neuropathy (diabetes, alcoholism...)
- Cauda equina syndrome or progressive neurologic deficit in the lower extremity
- Neurogenic bladder/bowel syndrome
- Arterial vascular disease-Vascular claudication
- Spinal stenosis, spondylolysis, spondylolisthesis
- Local infection at the injection site
- Presence of bleeding diathesis
- Neuro-degenerative diseases
- Uncontrolled diabetes, hypertension
- History of malignancy
- Uncontrolled psychiatric illness
- BMI over 40
- Allergy to injection substances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 14, 2022
First Posted
October 19, 2022
Study Start
November 1, 2021
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
October 19, 2022
Record last verified: 2022-10